- Home
- IKT vs WIA Comparison
IKT vs WIA Comparison
Compare IKT & WIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- WIA
- Stock Information
- Founded
- IKT 2008
- WIA 2003
- Country
- IKT United States
- WIA United States
- Employees
- IKT N/A
- WIA N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- WIA Trusts Except Educational Religious and Charitable
- Sector
- IKT Health Care
- WIA Finance
- Exchange
- IKT Nasdaq
- WIA Nasdaq
- Market Cap
- IKT 159.2M
- WIA 186.8M
- IPO Year
- IKT 2020
- WIA N/A
- Fundamental
- Price
- IKT $3.05
- WIA $7.98
- Analyst Decision
- IKT Strong Buy
- WIA
- Analyst Count
- IKT 2
- WIA 0
- Target Price
- IKT $6.50
- WIA N/A
- AVG Volume (30 Days)
- IKT 451.1K
- WIA 39.2K
- Earning Date
- IKT 11-14-2024
- WIA 01-01-0001
- Dividend Yield
- IKT N/A
- WIA 12.29%
- EPS Growth
- IKT N/A
- WIA N/A
- EPS
- IKT N/A
- WIA N/A
- Revenue
- IKT $1.00
- WIA N/A
- Revenue This Year
- IKT N/A
- WIA N/A
- Revenue Next Year
- IKT N/A
- WIA N/A
- P/E Ratio
- IKT N/A
- WIA N/A
- Revenue Growth
- IKT N/A
- WIA N/A
- 52 Week Low
- IKT $1.12
- WIA $7.56
- 52 Week High
- IKT $4.20
- WIA $8.91
- Technical
- Relative Strength Index (RSI)
- IKT 51.80
- WIA 27.99
- Support Level
- IKT $2.90
- WIA $7.96
- Resistance Level
- IKT $4.20
- WIA $8.31
- Average True Range (ATR)
- IKT 0.41
- WIA 0.08
- MACD
- IKT -0.07
- WIA -0.02
- Stochastic Oscillator
- IKT 11.54
- WIA 8.33
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation.